Actions halal du secteur santé
1,059 cotations américaines du secteur santé passent le filtre d’activité (0 non tranchées, 6 non conformes). Les 150 plus grandes figurent ci-dessous, par capitalisation.
| Action | Industrie | Capitalisation | Cours | Jour | Qualité | Dette & trésorerie |
|---|---|---|---|---|---|---|
| LLYEli Lilly and Company | Biotechnology: Pharmaceutical Preparations | $1.2T | $1,288.30 | +0.50% | — | Conforme |
| JNJJohnson & Johnson | Biotechnology: Pharmaceutical Preparations | $646.9B | $271.04 | +0.86% | — | Conforme |
| ABBVAbbVie Inc. | Biotechnology: Pharmaceutical Preparations | $506.1B | $285.99 | −0.14% | 54 | Non vérifié |
| UNHUnitedHealth Group Incorporated | Medical Specialities | $368.4B | $407.10 | −0.80% | — | Conforme |
| MRKMerck & Company Inc. | Biotechnology: Pharmaceutical Preparations | $349.9B | $140.93 | −0.63% | — | Non vérifié |
| NVSNovartis AG | Biotechnology: Pharmaceutical Preparations | $299.3B | $156.08 | −0.50% | — | Non vérifié |
| AZNAstraZeneca PLC | Biotechnology: Pharmaceutical Preparations | $263.7B | $169.51 | −0.34% | 64 | Non vérifié |
| AMGNAmgen Inc. | Biotechnology: Biological Products (No Diagnostic Substances) | $242.2B | $451.83 | +0.87% | 61 | Non vérifié |
| GILDGilead Sciences Inc. | Biotechnology: Biological Products (No Diagnostic Substances) | $197.3B | $159.20 | +0.08% | — | Non vérifié |
| ABTAbbott Laboratories | Biotechnology: Pharmaceutical Preparations | $178.4B | $102.64 | −0.45% | 45 | Non vérifié |
| NVONovo Nordisk A/S | Biotechnology: Pharmaceutical Preparations | $171.2B | $38.29 | −0.98% | — | Non vérifié |
| PFEPfizer Inc. | Biotechnology: Pharmaceutical Preparations | $169.9B | $29.45 | −1.17% | — | Non conforme |
| ISRGIntuitive Surgical Inc. | Industrial Specialties | $154.6B | $444.18 | −0.38% | — | Non vérifié |
| VRTXVertex Pharmaceuticals Incorporated | Biotechnology: Pharmaceutical Preparations | $132.1B | $529.69 | +1.66% | — | Non vérifié |
| BMYBristol-Myers Squibb Company | Biotechnology: Pharmaceutical Preparations | $125.7B | $60.57 | −1.59% | 55 | Non vérifié |
| MDTMedtronic plc. | Biotechnology: Electromedical & Electrotherapeutic Apparatus | $120.2B | $94.78 | +0.88% | — | Non vérifié |
| SYKStryker Corporation | Medical/Dental Instruments | $115.6B | $304.00 | +0.86% | — | Non vérifié |
| MCKMcKesson Corporation | Other Pharmaceuticals | $112.7B | $960.56 | −0.67% | — | Non vérifié |
| GSKGSK plc American Depositary Shares (Each representing two | Biotechnology: Pharmaceutical Preparations | $103.0B | $48.74 | −4.32% | — | Non vérifié |
| SNYSanofi ADS | Biotechnology: Pharmaceutical Preparations | $102.2B | $42.24 | +0.84% | — | Non vérifié |
| HCAHCA Healthcare Inc. | Hospital/Nursing Management | $97.4B | $463.22 | +2.95% | — | Non vérifié |
| ELVElevance Health Inc. | Medical Specialities | $91.1B | $414.41 | −1.68% | 54 | Non vérifié |
| MMM3M Company | Medical/Dental Instruments | $88.7B | $172.80 | +0.71% | — | Non vérifié |
| REGNRegeneron Pharmaceuticals Inc. | Biotechnology: Pharmaceutical Preparations | $84.0B | $813.27 | −0.35% | — | Non vérifié |
| MRNAModerna Inc. | Biotechnology: Biological Products (No Diagnostic Substances) | $83.0B | $214.16 | +2.98% | — | Non vérifié |
| CIThe Cigna Group | Medical Specialities | $78.8B | $295.00 | −1.10% | 53 | Non vérifié |
| BSXBoston Scientific Corporation | Medical/Dental Instruments | $65.3B | $42.43 | −5.84% | 67 | Non vérifié |
| TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of | Biotechnology: Pharmaceutical Preparations | $64.1B | $20.15 | −0.59% | — | Non vérifié |
| CORCencora Inc. | Other Pharmaceuticals | $62.1B | $324.35 | −0.31% | 50 | Non vérifié |
| NTRANatera Inc. | Medical Specialities | $59.2B | $424.42 | +3.31% | — | Non vérifié |
| CAHCardinal Health Inc. | Other Pharmaceuticals | $57.1B | $244.76 | −0.69% | 57 | Non vérifié |
| ARGXargenx SE American Depositary Shares | Biotechnology: Biological Products (No Diagnostic Substances) | $54.8B | $891.76 | +1.05% | 72 | Non vérifié |
| BDXBecton Dickinson and Company | Medical/Dental Instruments | $53.1B | $195.16 | +0.07% | 52 | Non vérifié |
| EWEdwards Lifesciences Corporation | Industrial Specialties | $52.3B | $91.78 | +1.06% | 65 | Non vérifié |
| HUMHumana Inc. | Medical Specialities | $49.8B | $411.87 | −0.72% | — | Non vérifié |
| TEVATeva Pharmaceutical Industries Limited | Biotechnology: Pharmaceutical Preparations | $47.1B | $39.97 | −1.04% | — | Non vérifié |
| IQVIQVIA Holdings Inc. | Biotechnology: Commercial Physical & Biological Resarch | $44.7B | $279.04 | +2.76% | — | Non vérifié |
| IDXXIDEXX Laboratories Inc. | Biotechnology: In Vitro & In Vivo Diagnostic Substances | $44.2B | $562.91 | +0.30% | — | Non vérifié |
| MDLNMedline Inc. | Medical/Dental Instruments | $42.6B | $32.37 | −0.03% | — | Non vérifié |
| ILMNIllumina Inc. | Medical Specialities | $42.2B | $288.79 | +3.33% | — | Non vérifié |
| ONCBeOne Medicines Ltd. American Depositary Shares | Biotechnology: Pharmaceutical Preparations | $41.6B | $373.36 | +2.00% | — | Non vérifié |
| RVMDRevolution Medicines Inc. | Biotechnology: Biological Products (No Diagnostic Substances) | $39.9B | $188.72 | +1.34% | — | Non vérifié |
| BTSGUBrightSpring Health Services Inc. Tangible Equity Unit | Medical/Nursing Services | $38.0B | $195.18 | +1.73% | — | Non vérifié |
| RPRXRoyalty Pharma plc | Biotechnology: Pharmaceutical Preparations | $37.5B | $64.82 | −0.70% | — | Non vérifié |
| BIIBBiogen Inc. | Biotechnology: Biological Products (No Diagnostic Substances) | $37.3B | $244.05 | −3.43% | 48 | Non vérifié |
| RMDResMed Inc. | Medical/Dental Instruments | $35.3B | $250.17 | −0.25% | — | Non vérifié |
| ALCAlcon Inc. | Ophthalmic Goods | $34.7B | $69.83 | +0.59% | 60 | Non vérifié |
| CNCCentene Corporation | Medical Specialities | $33.9B | $67.05 | −2.42% | 50 | Non vérifié |
| ZTSZoetis Inc. | Biotechnology: Pharmaceutical Preparations | $32.3B | $77.80 | −0.55% | — | Non vérifié |
| GEHCGE HealthCare Technologies Inc. | Medical Electronics | $32.1B | $75.82 | +6.62% | 53 | Non vérifié |
| ALNYAlnylam Pharmaceuticals Inc. | Biotechnology: Pharmaceutical Preparations | $30.3B | $232.40 | +2.47% | 70 | Non vérifié |
| DXCMDexCom Inc. | Medical/Dental Instruments | $29.6B | $78.62 | +0.08% | 75 | Non vérifié |
| WSTWest Pharmaceutical Services Inc. | Medical/Dental Instruments | $28.0B | $403.64 | +1.34% | — | Non vérifié |
| GMABGenmab A/S ADS | Biotechnology: Pharmaceutical Preparations | $27.9B | $57.29 | +28.25% | — | Non vérifié |
| LHLabcorp Holdings Inc. | Medical Specialities | $26.9B | $360.25 | +8.78% | — | Non vérifié |
| DGXQuest Diagnostics Incorporated | Medical Specialities | $26.7B | $245.62 | +1.26% | 54 | Non vérifié |
| ROIVRoivant Sciences Ltd. Common Shares | Biotechnology: Pharmaceutical Preparations | $26.4B | $37.11 | +1.56% | — | Non vérifié |
| PHGKoninklijke Philips N.V. NY Registry Shares | Medical Electronics | $26.0B | $27.03 | +2.35% | — | Non vérifié |
| UTHRUnited Therapeutics Corporation | Biotechnology: Pharmaceutical Preparations | $25.4B | $586.48 | −0.80% | — | Non vérifié |
| GHGuardant Health Inc. | Medical Specialities | $23.9B | $182.59 | +2.54% | — | Non vérifié |
| INCYIncyte Corp. | Biotechnology: Commercial Physical & Biological Resarch | $23.6B | $116.87 | +0.23% | — | Non vérifié |
| STESTERIS plc (Ireland) | Industrial Specialties | $22.3B | $228.78 | +0.13% | — | Non vérifié |
| BNTXBioNTech SE American Depositary Share | Biotechnology: Biological Products (No Diagnostic Substances) | $21.9B | $87.99 | +1.07% | 31 | Non vérifié |
| VTRSViatris Inc. | Biotechnology: Pharmaceutical Preparations | $21.5B | $18.77 | +0.27% | — | Non vérifié |
| THCTenet Healthcare Corporation | Hospital/Nursing Management | $21.1B | $268.50 | +2.46% | — | Non vérifié |
| INSMInsmed Incorporated | Biotechnology: Pharmaceutical Preparations | $20.7B | $96.98 | +2.13% | — | Non vérifié |
| MEDPMedpace Holdings Inc. | Biotechnology: Commercial Physical & Biological Resarch | $18.8B | $692.68 | +2.80% | — | Non vérifié |
| ZBHZimmer Biomet Holdings Inc. | Industrial Specialties | $18.3B | $96.39 | +0.34% | — | Non vérifié |
| CRLCharles River Laboratories International Inc. | Biotechnology: Commercial Physical & Biological Resarch | $17.1B | $373.98 | +4.22% | 37 | Non vérifié |
| ASNDAscendis Pharma A/S Ordinary Share | Biotechnology: Pharmaceutical Preparations | $16.2B | $249.55 | +1.50% | 75 | Non vérifié |
| EXELExelixis Inc. | Biotechnology: Biological Products (No Diagnostic Substances) | $16.2B | $66.28 | +1.42% | 83 | Non vérifié |
| NBIXNeurocrine Biosciences Inc. | Biotechnology: Biological Products (No Diagnostic Substances) | $14.8B | $145.53 | −0.32% | — | Non vérifié |
| HALOHalozyme Therapeutics Inc. | Biotechnology: Biological Products (No Diagnostic Substances) | $14.6B | $130.03 | +1.19% | — | Non vérifié |
| ULSUL Solutions Inc. | Precision Instruments | $14.6B | $72.40 | +0.28% | — | Non vérifié |
| SOLVSolventum Corporation | Medical/Dental Instruments | $14.1B | $81.85 | −1.36% | — | Non vérifié |
| ICLRICON plc | Biotechnology: Commercial Physical & Biological Resarch | $14.0B | $214.16 | +17.04% | — | Non vérifié |
| BBIOBridgeBio Pharma Inc. | Biotechnology: Pharmaceutical Preparations | $13.6B | $70.82 | +2.09% | 45 | Non vérifié |
| JAZZJazz Pharmaceuticals plc | Biotechnology: Pharmaceutical Preparations | $13.4B | $205.06 | −0.83% | — | Non vérifié |
| BAXBaxter International Inc. | Medical/Dental Instruments | $12.9B | $25.46 | +2.17% | 39 | Non vérifié |
| PENPenumbra Inc. | Medical/Dental Instruments | $12.8B | $318.31 | −1.77% | — | Non vérifié |
| SNNSmith & Nephew SNATS Inc. | Industrial Specialties | $12.6B | $30.12 | +0.07% | — | Non vérifié |
| FMSFresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share) | Misc Health and Biotechnology Services | $12.6B | $22.62 | +0.53% | 48 | Non vérifié |
| SMMTSummit Therapeutics Inc. | Biotechnology: Pharmaceutical Preparations | $12.3B | $15.77 | +2.87% | — | Non vérifié |
| EHCEncompass Health Corporation | Hospital/Nursing Management | $12.0B | $122.09 | +0.46% | 59 | Non vérifié |
| DVADaVita Inc. | Misc Health and Biotechnology Services | $11.6B | $183.93 | +1.23% | 50 | Non vérifié |
| BTSGBrightSpring Health Services Inc. | Medical/Nursing Services | $11.5B | $59.46 | +1.88% | 64 | Non vérifié |
| RDYDr. Reddy's Laboratories Ltd | Biotechnology: Pharmaceutical Preparations | $11.5B | $14.15 | +2.91% | — | Non vérifié |
| COOThe Cooper Companies Inc. | Ophthalmic Goods | $11.4B | $59.41 | −0.78% | 55 | Non vérifié |
| TECHBio-Techne Corp | Biotechnology: Biological Products (No Diagnostic Substances) | $11.4B | $72.69 | +0.12% | — | Non vérifié |
| ELANElanco Animal Health Incorporated | Biotechnology: Pharmaceutical Preparations | $11.3B | $22.65 | 0.00% | 43 | Non vérifié |
| GMEDGlobus Medical Inc. | Medical/Dental Instruments | $10.9B | $81.26 | +0.44% | — | Non vérifié |
| ALGNAlign Technology Inc. | Industrial Specialties | $10.8B | $153.62 | +1.10% | 66 | Non vérifié |
| BMRNBioMarin Pharmaceutical Inc. | Biotechnology: Pharmaceutical Preparations | $10.7B | $56.00 | +1.17% | 54 | Non vérifié |
| GKOSGlaukos Corporation | Medical/Dental Instruments | $10.7B | $181.43 | +0.14% | — | Non vérifié |
| TWSTTwist Bioscience Corporation | Biotechnology: Biological Products (No Diagnostic Substances) | $10.6B | $173.45 | +8.51% | — | Non vérifié |
| UHSUniversal Health Services Inc. | Hospital/Nursing Management | $10.5B | $172.18 | −2.90% | — | Non vérifié |
| MOHMolina Healthcare Inc | Medical Specialities | $10.4B | $198.10 | −0.68% | — | Non vérifié |
| PODDInsulet Corporation | Medical/Dental Instruments | $10.4B | $148.93 | −0.60% | — | Non vérifié |
| SYRESpyre Therapeutics Inc. | Biotechnology: Pharmaceutical Preparations | $10.3B | $99.75 | +0.71% | — | Non vérifié |
| QGENQiagen N.V. Common Shares | Biotechnology: Biological Products (No Diagnostic Substances) | $10.3B | $50.33 | +0.32% | — | Non vérifié |
| MDGLMadrigal Pharmaceuticals Inc. | Biotechnology: Pharmaceutical Preparations | $10.2B | $431.00 | −2.12% | — | Non vérifié |
| ENSGThe Ensign Group Inc. | Hospital/Nursing Management | $9.9B | $184.11 | +8.62% | 60 | Non vérifié |
| KYMRKymera Therapeutics Inc. | Biotechnology: Biological Products (No Diagnostic Substances) | $9.8B | $122.51 | +4.20% | — | Non vérifié |
| OSCROscar Health Inc. | Medical Specialities | $9.7B | $30.48 | −2.78% | — | Non vérifié |
| PCVXVaxcyte Inc. | Biotechnology: Biological Products (No Diagnostic Substances) | $9.5B | $61.46 | +1.30% | — | Non vérifié |
| CAICaris Life Sciences Inc. | Medical Specialities | $9.5B | $35.45 | +5.29% | 64 | Non vérifié |
| KRYSKrystal Biotech Inc. | Biotechnology: Biological Products (No Diagnostic Substances) | $9.5B | $321.42 | +0.26% | — | Non vérifié |
| CORTCorcept Therapeutics Incorporated | Biotechnology: Pharmaceutical Preparations | $9.5B | $86.28 | −1.50% | 72 | Non vérifié |
| HSICHenry Schein Inc. | Medical Specialities | $9.4B | $84.96 | +0.84% | — | Non vérifié |
| IBRXImmunityBio Inc. | Biotechnology: Biological Products (No Diagnostic Substances) | $9.1B | $8.81 | +2.09% | — | Non vérifié |
| PTGXProtagonist Therapeutics Inc. | Biotechnology: Pharmaceutical Preparations | $9.1B | $142.14 | +0.72% | — | Non vérifié |
| TGTXTG Therapeutics Inc. | Biotechnology: Pharmaceutical Preparations | $8.6B | $57.40 | +1.70% | — | Non vérifié |
| RGENRepligen Corporation | Biotechnology: Biological Products (No Diagnostic Substances) | $8.6B | $184.69 | +5.06% | — | Non vérifié |
| CYTKCytokinetics Incorporated | Biotechnology: Pharmaceutical Preparations | $8.6B | $61.28 | −0.39% | 24 | Non vérifié |
| ARWRArrowhead Pharmaceuticals Inc. | Biotechnology: Pharmaceutical Preparations | $8.3B | $60.21 | +2.00% | 48 | Non vérifié |
| ABVXAbivax SA American Depositary Shares | Biotechnology: Pharmaceutical Preparations | $7.6B | $89.84 | +3.26% | 24 | Non vérifié |
| PACSPACS Group Inc. | Hospital/Nursing Management | $7.6B | $49.06 | +2.53% | — | Non vérifié |
| PRAXPraxis Precision Medicines Inc. | Biotechnology: Pharmaceutical Preparations | $7.5B | $285.48 | +6.69% | — | Non vérifié |
| AMRXAmneal Pharmaceuticals Inc. | Biotechnology: Pharmaceutical Preparations | $7.5B | $21.14 | −1.40% | 45 | Non vérifié |
| AXSMAxsome Therapeutics Inc. | Biotechnology: Pharmaceutical Preparations | $7.4B | $143.51 | +0.92% | 42 | Non vérifié |
| ALKSAlkermes plc | Biotechnology: Pharmaceutical Preparations | $7.4B | $45.25 | +2.10% | 59 | Non vérifié |
| IONSIonis Pharmaceuticals Inc. | Biotechnology: Pharmaceutical Preparations | $7.3B | $44.90 | +2.14% | — | Non vérifié |
| KNSAKiniksa Pharmaceuticals International plc | Biotechnology: Pharmaceutical Preparations | $7.0B | $95.18 | +6.70% | — | Non vérifié |
| MSAMSA Safety Incorporated | Industrial Specialties | $6.9B | $177.16 | −1.12% | — | Non vérifié |
| GRALGRAIL Inc. | Medical Specialities | $6.7B | $157.88 | +4.83% | — | Non vérifié |
| CHEChemed Corp | Medical/Nursing Services | $6.7B | $533.36 | +4.77% | 63 | Non vérifié |
| IOVAIovance Biotherapeutics Inc. | Biotechnology: Biological Products (No Diagnostic Substances) | $6.6B | $14.81 | +1.58% | — | Non vérifié |
| LNTHLantheus Holdings Inc. | Biotechnology: In Vitro & In Vivo Diagnostic Substances | $6.5B | $100.10 | −0.05% | — | Non vérifié |
| HIMSHims & Hers Health Inc. | Medical/Nursing Services | $6.5B | $29.32 | +5.01% | — | Conforme |
| RYTMRhythm Pharmaceuticals Inc. | Biotechnology: Pharmaceutical Preparations | $6.3B | $91.97 | −0.23% | — | Non vérifié |
| ORKAOruka Therapeutics Inc. | Biotechnology: In Vitro & In Vivo Diagnostic Substances | $6.3B | $95.97 | +0.17% | — | Non vérifié |
| BLCOBausch + Lomb Corporation Common Shares | Ophthalmic Goods | $6.3B | $20.40 | +15.78% | 40 | Non vérifié |
| LGNDLigand Pharmaceuticals Incorporated | Biotechnology: Pharmaceutical Preparations | $6.2B | $318.78 | +2.26% | — | Non vérifié |
| IMVTImmunovant Inc. | Biotechnology: Biological Products (No Diagnostic Substances) | $6.0B | $29.42 | +1.87% | — | Non vérifié |
| TFXTeleflex Incorporated | Medical/Dental Instruments | $5.9B | $138.98 | −0.01% | — | Non vérifié |
| MANEVeradermics Incorporated | Biotechnology: Pharmaceutical Preparations | $5.9B | $143.83 | +2.21% | — | Non vérifié |
| BLTEBelite Bio Inc American Depositary Shares | Biotechnology: Pharmaceutical Preparations | $5.9B | $148.72 | +2.06% | 50 | Non vérifié |
| RDNTRadNet Inc. | Medical Specialities | $5.8B | $73.54 | 0.00% | — | Non vérifié |
| KODKodiak Sciences Inc | Biotechnology: Biological Products (No Diagnostic Substances) | $5.7B | $97.04 | +6.26% | — | Non vérifié |
| MMSIMerit Medical Systems Inc. | Medical/Dental Instruments | $5.6B | $92.21 | −1.41% | — | Non vérifié |
| CGONCG Oncology Inc. Common stock | Biotechnology: Biological Products (No Diagnostic Substances) | $5.6B | $63.96 | +1.62% | 31 | Non vérifié |
| GRFSGrifols S.A. American Depositary Shares | Biotechnology: Pharmaceutical Preparations | $5.6B | $8.12 | +0.25% | — | Non vérifié |
| MIRMMirum Pharmaceuticals Inc. | Biotechnology: Pharmaceutical Preparations | $5.6B | $85.81 | +0.29% | — | Non vérifié |
| COGTCogent Biosciences Inc. | Biotechnology: Pharmaceutical Preparations | $5.6B | $32.23 | +0.69% | 38 | Non vérifié |
| HAEHaemonetics Corporation | Medical/Dental Instruments | $5.5B | $118.32 | −1.38% | — | Non vérifié |
| BLLNBillionToOne Inc. | Medical Specialities | $5.4B | $114.00 | −0.06% | 64 | Non vérifié |
| STVNStevanato Group S.p.A. | Medical/Dental Instruments | $5.4B | $19.43 | −1.07% | — | Non vérifié |
| MMEDMiniMed Group Inc. | Medical/Dental Instruments | $5.3B | $19.21 | +1.48% | — | Non vérifié |
| ERASErasca Inc. | Biotechnology: Pharmaceutical Preparations | $5.3B | $15.12 | −0.66% | 45 | Non vérifié |
| SHCSotera Health Company | Misc Health and Biotechnology Services | $5.3B | $18.65 | +0.87% | — | Non vérifié |
« Dette & trésorerie » est le critère des 30 % de l’AAOIFI, vérifié lorsque le bilan est disponible. « Qualité » est la note globale sur 100, face à tout le marché américain.
Outils pour l’investisseur musulman
ETF et fonds halalETF et fonds communs conformes à la charia, avec leurs rendements.Calculateur de zakat sur les actionsLa zakat due sur vos actions, en spéculation ou à long terme.Calculateur de purificationLa part de vos dividendes à donner.
Autres secteurs
consommation discrétionnairetechnologieindustrieénergieservices publicsmatériaux de baseconsommation de basetélécommunicationsimmobilierdiversfinance
Comment fonctionne le filtre
- Activité. Les sociétés dont l’activité principale est illicite sont exclues : banque et assurance conventionnelles, alcool, tabac, jeux d’argent, porc, divertissement pour adultes et assimilés. Les cotations dont l’activité ne peut être tranchée sont marquées « non tranché ».
- Dette et trésorerie (AAOIFI). La dette portant intérêt, et la trésorerie avec les dépôts rémunérés, doivent chacune rester sous 30 % de la capitalisation. Ces ratios sont vérifiés pour les 80 sociétés dont le bilan complet est disponible ; 62 les respectent.
- Non appliqué : le critère des 5 %. Les revenus non permis (comme les intérêts) doivent rester sous 5 % du chiffre d’affaires. Aucune source gratuite ne publie le détail nécessaire : vérifiez-le auprès d’un savant ou d’un service de filtrage spécialisé avant d’investir.
Filtre automatisé à titre d’information, ni fatwa ni conseil en investissement. Le critère des 5 % de revenus non permis n’est pas appliqué : vérifiez auprès d’un savant avant de décider. Filtre mis à jour le: 2026-10-29.